Evaluation of the Effect of Alkaloid Berberine on the Positive and Negative Symptoms of the Patients with Schizophrenia: A Double-Blind Randomized Placebo-Controlled Clinical Trial

Schizophrenia is a severe psychiatric condition that affects approximately 1% of the global population. Over the last decade, the efficacy of berberine as a complementary therapy in psychiatric diseases without significant side effects has been demonstrated. Therefore, this study assessed the effec...

Full description

Bibliographic Details
Main Authors: Ebrahim Moghimi Sarani, Fatemeh Ghorbannezhad, Mohammad Hassan Meshkibaf, Marjan Shakibaee, Seyed Hamdollah Mosavat
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2022-09-01
Series:Traditional and Integrative Medicine
Subjects:
Online Access:https://jtim.tums.ac.ir/index.php/jtim/article/view/597